<p>随着全球市场对经济数据和地缘政治发展的反应各异，亚洲股市表现出韧性，中国和日本的指数在国内需求强劲和人工智能驱动的乐观情绪中录得上涨。在这种环境下，识别被低估的股票需要关注那些尽管面临更广泛市场不确定性，但仍展现出强大基本面和增长潜力的公司。</p>
<h3>基于现金流的亚洲十大被低估股票</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>当前价格</strong></td>
<td><strong>公允价值（估算）</strong></td>
<td><strong>折扣（估算）</strong></td>
</tr>
<tr>
<td>Yurtec (TSE:1934)</td>
<td>¥2498.00</td>
<td>¥4969.75</td>
<td>49.7%</td>
</tr>
<tr>
<td>TOKYO BASELtd (TSE:3415)</td>
<td>¥376.00</td>
<td>¥751.82</td>
<td>50%</td>
</tr>
<tr>
<td>SkyCity Entertainment Group (NZSE:SKC)</td>
<td>NZ$0.63</td>
<td>NZ$1.23</td>
<td>48.9%</td>
</tr>
<tr>
<td>Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990)</td>
<td>HK$449.20</td>
<td>HK$898.30</td>
<td>50%</td>
</tr>
<tr>
<td>Shenzhen Dynanonic (SZSE:300769)</td>
<td>CN¥80.29</td>
<td>CN¥156.46</td>
<td>48.7%</td>
</tr>
<tr>
<td>Plus Alpha ConsultingLtd (TSE:4071)</td>
<td>¥2339.00</td>
<td>¥4672.72</td>
<td>49.9%</td>
</tr>
<tr>
<td>Intco Medical Technology (SZSE:300677)</td>
<td>CN¥51.75</td>
<td>CN¥100.82</td>
<td>48.7%</td>
</tr>
<tr>
<td>Info-Tech Systems (SGX:ITS)</td>
<td>SGD0.98</td>
<td>SGD1.92</td>
<td>49%</td>
</tr>
<tr>
<td>Horizon Robotics (SEHK:9660)</td>
<td>HK$6.87</td>
<td>HK$13.54</td>
<td>49.2%</td>
</tr>
<tr>
<td>Beijing Luzhu Biotechnology (SEHK:2480)</td>
<td>HK$20.04</td>
<td>HK$39.19</td>
<td>48.9%</td>
</tr>
</tbody>
</table>
<p>点击这里查看我们基于现金流的 204 只被低估亚洲股票的完整列表。</p>
<p>我们将从我们的筛选结果中选取一些进行分析。</p>
<h2>RFHIC (KOSDAQ:A218410)</h2>
<p><strong>概述：</strong> RFHIC 公司设计和制造无线基础设施、商业和军事雷达以及射频能源应用的射频和微波组件，市值为 2.64 万亿韩元。</p>
<p><strong>运营：</strong> 公司的收入来源包括无线基础设施、商业和军事雷达以及射频能源应用，服务于国内和国际市场。</p>
<p><strong>公允价值折扣估算：</strong> 24%</p>
<p>RFHIC 的交易价格为 104,000 韩元，显著低于其估算的未来现金流价值 136,754.05 韩元，表明潜在的低估。尽管股价波动和利润率从 22.3% 下降至 15.4%，但去年盈利增长了 11.7%，预计未来三年将以 29.43% 的年率显著增长，超过韩国市场 13.6% 的收入增长率。</p>
<ul>
<li>我们最近的增长报告提供了对 RFHIC 商业前景的乐观预测。</li>
<li>点击这里访问我们的完整资产负债表健康报告，以了解 RFHIC 的动态。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/8d35b4bb-9ac3-4df3-8886-b943244bee99/chart/dcf/query-dGhlbWU9bGlnaHQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/8d35b4bb-9ac3-4df3-8886-b943244bee99/chart/dcf/query-dGhlbWU9bGlnaHQ"/></p>
<p>KOSDAQ:A218410 截至 2026 年 5 月的折现现金流</p>
<h2>GKG Precision Machine (SZSE:301338)</h2>
<p><strong>概述：</strong> GKG Precision Machine 有限公司在中国和国际上提供精密自动化设备，市值为 213.8 亿人民币。</p>
<p><strong>运营：</strong> GKG Precision Machine 有限公司通过提供精密自动化设备在国内和国际市场上产生收入。</p>
<p><strong>公允价值折扣估算：</strong> 11%</p>
<p>GKG Precision Machine 的交易价格为 200.95 人民币，低于其估算的未来现金流价值 225.81 人民币，表明潜在的低估。该公司报告了 2026 年第一季度强劲的业绩，销售额为 3.3965 亿人民币，净收入为 6498 万人民币，反映出显著的同比增长。尽管股价波动，去年盈利增长了 135.1%，预计未来三年将以 34.36% 的年率显著增长，超出市场预期。</p>
<ul>
<li>我们的 GKG Precision Machine 增长报告中的分析暗示未来财务表现将强劲。</li>
<li>点击探索我们在 GKG Precision Machine 资产负债表健康报告中的详细发现。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/f983ee38-85a1-44d1-8078-fc07d059c0f7/chart/dcf/query-dGhlbWU9bGlnaHQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/f983ee38-85a1-44d1-8078-fc07d059c0f7/chart/dcf/query-dGhlbWU9bGlnaHQ"/></p>
<p>SZSE:301338 截至 2026 年 5 月的折现现金流</p>
<h2>Nippon Chemi-Con (TSE:6997)</h2>
<p><strong>概述：</strong> Nippon Chemi-Con 公司涉及铝电容器和其他电容器、精密机械组件及电子设备的制造和销售，业务遍及日本、中国、美洲、欧洲及国际市场，市值为 763.9 亿日元。</p>
<p><strong>运营：</strong> 公司的收入主要来自其电容器部门，产生了 1272 亿日元的收入。</p>
<p><strong>公允价值折扣估算：</strong> 45.9%</p>
<p>Nippon Chemi-Con 的交易价格为 3170 日元，显著低于其估算的未来现金流价值 5864.2 日元。尽管去年盈利增长了 45.3%，预计年利润将增加 52%，但利息支付未能得到盈利的良好覆盖。该公司最近宣布通过向日本开发银行发行优先股筹集 90 亿日元的私募，增加了在股价波动中的财务灵活性。</p>
<ul>
<li>根据我们最近的增长报告，Nippon Chemi-Con 的财务表现可能会超过当前水平。</li>
<li>点击这里阅读 Nippon Chemi-Con 的资产负债表健康报告，获取深入的视角。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/315324ed-d0c8-4ff1-baae-94405139c1a7/chart/dcf/query-dGhlbWU9bGlnaHQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/315324ed-d0c8-4ff1-baae-94405139c1a7/chart/dcf/query-dGhlbWU9bGlnaHQ"/></p>
<p>TSE:6997 截至 2026 年 5 月的折现现金流</p>
<h2>将想法转化为行动</h2>
<ul>
<li>在这里调查我们基于现金流的 204 只被低估亚洲股票的完整阵容。</li>
<li>你是否已经将投资组合多样化到这些公司？利用 Simply Wall St 的投资组合功能，密切关注影响你投资的市场动态。</li>
<li>使用 Simply Wall St 提升你的投资组合，这是寻求全球市场覆盖的投资者的终极应用。</li>
</ul>
<h2>想探索一些替代方案吗？</h2>
<ul>
<li>探索尚未获得显著分析师关注的高表现小型公司。</li>
<li>通过稳健的分红支付者来多样化您的投资组合，以应对潜在的市场波动。</li>
<li>充实您的投资组合，选择那些显示出强劲增长潜力的公司，这些公司得到了分析师和管理层的乐观展望支持。</li>
</ul>
<p><em>这篇文章来自 Simply Wall St，内容具有一般性。<strong>我们基于历史数据和分析师预测提供评论，采用无偏见的方法，我们的文章并不构成财务建议。它不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。</strong> 我们旨在为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
<h3><strong>新功能：</strong> 在一个地方管理您的所有股票投资组合</h3>
<p>我们为股票投资者创建了 <strong>终极投资组合助手</strong>，<strong>而且是免费的。</strong></p>
<p>• 连接无限数量的投资组合，并以一种货币查看您的总额</p>
<p>• 通过电子邮件或手机接收新的警告信号或风险提示</p>
<p>• 跟踪您股票的公允价值</p>
<p>免费试用演示投资组合</p>

6997

3415

1934

<p>亚洲股市在全球市场波动中表现出韧性，重点关注被低估的股票。被识别的关键公司包括 Yurtec、TOKYO BASE 和 Nippon Chemi-Con，这些公司的交易价格均低于其估计的公允价值。例如，Nippon Chemi-Con 的交易价格为¥3,170，远低于其估计价值¥5,864.2，尽管其盈利增长强劲。分析师建议，这些股票在更广泛的市场不确定性中可能提供增长潜力。文章强调了在当前经济环境中，强劲基本面在识别投资机会中的重要性</p>

<p>As global markets experience varied reactions to economic data and geopolitical developments, Asian equities have shown resilience, with Chinese and Japanese indices posting gains amid positive domestic demand and AI-driven optimism. In this environment, identifying undervalued stocks requires a focus on companies that demonstrate strong fundamentals and potential for growth despite broader market uncertainties.</p>
<div class="lb-trans"><p>随着全球市场对经济数据和地缘政治发展的反应各异，亚洲股市表现出韧性，中国和日本的指数在国内需求强劲和人工智能驱动的乐观情绪中录得上涨。在这种环境下，识别被低估的股票需要关注那些尽管面临更广泛市场不确定性，但仍展现出强大基本面和增长潜力的公司。</p>
</div><h3>Top 10 Undervalued Stocks Based On Cash Flows In Asia</h3>
<div class="lb-trans"><h3>基于现金流的亚洲十大被低估股票</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Current Price</strong></td>
<td><strong>Fair Value (Est)</strong></td>
<td><strong>Discount (Est)</strong></td>
</tr>
<tr>
<td>Yurtec (TSE:1934)</td>
<td>¥2498.00</td>
<td>¥4969.75</td>
<td>49.7%</td>
</tr>
<tr>
<td>TOKYO BASELtd (TSE:3415)</td>
<td>¥376.00</td>
<td>¥751.82</td>
<td>50%</td>
</tr>
<tr>
<td>SkyCity Entertainment Group (NZSE:SKC)</td>
<td>NZ$0.63</td>
<td>NZ$1.23</td>
<td>48.9%</td>
</tr>
<tr>
<td>Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990)</td>
<td>HK$449.20</td>
<td>HK$898.30</td>
<td>50%</td>
</tr>
<tr>
<td>Shenzhen Dynanonic (SZSE:300769)</td>
<td>CN¥80.29</td>
<td>CN¥156.46</td>
<td>48.7%</td>
</tr>
<tr>
<td>Plus Alpha ConsultingLtd (TSE:4071)</td>
<td>¥2339.00</td>
<td>¥4672.72</td>
<td>49.9%</td>
</tr>
<tr>
<td>Intco Medical Technology (SZSE:300677)</td>
<td>CN¥51.75</td>
<td>CN¥100.82</td>
<td>48.7%</td>
</tr>
<tr>
<td>Info-Tech Systems (SGX:ITS)</td>
<td>SGD0.98</td>
<td>SGD1.92</td>
<td>49%</td>
</tr>
<tr>
<td>Horizon Robotics (SEHK:9660)</td>
<td>HK$6.87</td>
<td>HK$13.54</td>
<td>49.2%</td>
</tr>
<tr>
<td>Beijing Luzhu Biotechnology (SEHK:2480)</td>
<td>HK$20.04</td>
<td>HK$39.19</td>
<td>48.9%</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>当前价格</strong></td>
<td><strong>公允价值（估算）</strong></td>
<td><strong>折扣（估算）</strong></td>
</tr>
<tr>
<td>Yurtec (TSE:1934)</td>
<td>¥2498.00</td>
<td>¥4969.75</td>
<td>49.7%</td>
</tr>
<tr>
<td>TOKYO BASELtd (TSE:3415)</td>
<td>¥376.00</td>
<td>¥751.82</td>
<td>50%</td>
</tr>
<tr>
<td>SkyCity Entertainment Group (NZSE:SKC)</td>
<td>NZ$0.63</td>
<td>NZ$1.23</td>
<td>48.9%</td>
</tr>
<tr>
<td>Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990)</td>
<td>HK$449.20</td>
<td>HK$898.30</td>
<td>50%</td>
</tr>
<tr>
<td>Shenzhen Dynanonic (SZSE:300769)</td>
<td>CN¥80.29</td>
<td>CN¥156.46</td>
<td>48.7%</td>
</tr>
<tr>
<td>Plus Alpha ConsultingLtd (TSE:4071)</td>
<td>¥2339.00</td>
<td>¥4672.72</td>
<td>49.9%</td>
</tr>
<tr>
<td>Intco Medical Technology (SZSE:300677)</td>
<td>CN¥51.75</td>
<td>CN¥100.82</td>
<td>48.7%</td>
</tr>
<tr>
<td>Info-Tech Systems (SGX:ITS)</td>
<td>SGD0.98</td>
<td>SGD1.92</td>
<td>49%</td>
</tr>
<tr>
<td>Horizon Robotics (SEHK:9660)</td>
<td>HK$6.87</td>
<td>HK$13.54</td>
<td>49.2%</td>
</tr>
<tr>
<td>Beijing Luzhu Biotechnology (SEHK:2480)</td>
<td>HK$20.04</td>
<td>HK$39.19</td>
<td>48.9%</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 204 stocks from our Undervalued Asian Stocks Based On Cash Flows screener.</p>
<div class="lb-trans"><p>点击这里查看我们基于现金流的 204 只被低估亚洲股票的完整列表。</p>
</div><p>We'll examine a selection from our screener results.</p>
<div class="lb-trans"><p>我们将从我们的筛选结果中选取一些进行分析。</p>
</div><h2>RFHIC (KOSDAQ:A218410)</h2>
<div class="lb-trans"><h2>RFHIC (KOSDAQ:A218410)</h2>
</div><p><strong>Overview:</strong> RFHIC Corporation designs and manufactures RF and microwave components for wireless infrastructure, commercial and military radar, and RF energy applications globally, with a market cap of ₩2.64 trillion.</p>
<div class="lb-trans"><p><strong>概述：</strong> RFHIC 公司设计和制造无线基础设施、商业和军事雷达以及射频能源应用的射频和微波组件，市值为 2.64 万亿韩元。</p>
</div><p><strong>Operations:</strong> The company's revenue segments include wireless infrastructure, commercial and military radar, and RF energy applications, serving both domestic and international markets.</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入来源包括无线基础设施、商业和军事雷达以及射频能源应用，服务于国内和国际市场。</p>
</div><p><strong>Estimated Discount To Fair Value:</strong> 24%</p>
<div class="lb-trans"><p><strong>公允价值折扣估算：</strong> 24%</p>
</div><p>RFHIC is trading at ₩104,000, significantly below its estimated future cash flow value of ₩136,754.05, indicating potential undervaluation. Despite a volatile share price and declining profit margins from 22.3% to 15.4%, earnings grew by 11.7% last year and are forecast to grow significantly at 29.43% annually over the next three years, outpacing the KR market's revenue growth rate of 13.6%.</p>
<div class="lb-trans"><p>RFHIC 的交易价格为 104,000 韩元，显著低于其估算的未来现金流价值 136,754.05 韩元，表明潜在的低估。尽管股价波动和利润率从 22.3% 下降至 15.4%，但去年盈利增长了 11.7%，预计未来三年将以 29.43% 的年率显著增长，超过韩国市场 13.6% 的收入增长率。</p>
</div><ul>
<li>Insights from our recent growth report point to a promising forecast for RFHIC's business outlook.</li>
<li>Click here and access our complete balance sheet health report to understand the dynamics of RFHIC.</li>
</ul>
<div class="lb-trans"><ul>
<li>我们最近的增长报告提供了对 RFHIC 商业前景的乐观预测。</li>
<li>点击这里访问我们的完整资产负债表健康报告，以了解 RFHIC 的动态。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/8d35b4bb-9ac3-4df3-8886-b943244bee99/chart/dcf/query-dGhlbWU9bGlnaHQ" alt="" original-src="https://images.simplywall.st/company/8d35b4bb-9ac3-4df3-8886-b943244bee99/chart/dcf?theme=light"/></p>
<p>KOSDAQ:A218410 Discounted Cash Flow as at May 2026</p>
<div class="lb-trans"><p>KOSDAQ:A218410 截至 2026 年 5 月的折现现金流</p>
</div><h2>GKG Precision Machine (SZSE:301338)</h2>
<div class="lb-trans"><h2>GKG Precision Machine (SZSE:301338)</h2>
</div><p><strong>Overview:</strong> GKG Precision Machine Co., Ltd. provides precision automation equipment both in China and internationally, with a market cap of CN¥21.38 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> GKG Precision Machine 有限公司在中国和国际上提供精密自动化设备，市值为 213.8 亿人民币。</p>
</div><p><strong>Operations:</strong> GKG Precision Machine Co., Ltd. generates revenue through the provision of precision automation equipment across domestic and international markets.</p>
<div class="lb-trans"><p><strong>运营：</strong> GKG Precision Machine 有限公司通过提供精密自动化设备在国内和国际市场上产生收入。</p>
</div><p><strong>Estimated Discount To Fair Value:</strong> 11%</p>
<div class="lb-trans"><p><strong>公允价值折扣估算：</strong> 11%</p>
</div><p>GKG Precision Machine, trading at CN¥200.95, is below its estimated future cash flow value of CN¥225.81, suggesting potential undervaluation. The company reported strong Q1 2026 results with sales of CN¥339.65 million and net income of CN¥64.98 million, reflecting significant year-over-year growth. Despite a volatile share price, earnings grew by 135.1% last year and are projected to grow significantly at 34.36% annually over the next three years, surpassing market expectations.</p>
<div class="lb-trans"><p>GKG Precision Machine 的交易价格为 200.95 人民币，低于其估算的未来现金流价值 225.81 人民币，表明潜在的低估。该公司报告了 2026 年第一季度强劲的业绩，销售额为 3.3965 亿人民币，净收入为 6498 万人民币，反映出显著的同比增长。尽管股价波动，去年盈利增长了 135.1%，预计未来三年将以 34.36% 的年率显著增长，超出市场预期。</p>
</div><ul>
<li>The analysis detailed in our GKG Precision Machine growth report hints at robust future financial performance.</li>
<li>Click to explore a detailed breakdown of our findings in GKG Precision Machine's balance sheet health report.</li>
</ul>
<div class="lb-trans"><ul>
<li>我们的 GKG Precision Machine 增长报告中的分析暗示未来财务表现将强劲。</li>
<li>点击探索我们在 GKG Precision Machine 资产负债表健康报告中的详细发现。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/f983ee38-85a1-44d1-8078-fc07d059c0f7/chart/dcf/query-dGhlbWU9bGlnaHQ" alt="" original-src="https://images.simplywall.st/company/f983ee38-85a1-44d1-8078-fc07d059c0f7/chart/dcf?theme=light"/></p>
<p>SZSE:301338 Discounted Cash Flow as at May 2026</p>
<div class="lb-trans"><p>SZSE:301338 截至 2026 年 5 月的折现现金流</p>
</div><h2>Nippon Chemi-Con (TSE:6997)</h2>
<div class="lb-trans"><h2>Nippon Chemi-Con (TSE:6997)</h2>
</div><p><strong>Overview:</strong> Nippon Chemi-Con Corporation is involved in the manufacturing and sale of aluminum and other capacitors, precision mechanical components, and electronics equipment across Japan, China, the Americas, Europe, and internationally with a market cap of ¥76.39 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Nippon Chemi-Con 公司涉及铝电容器和其他电容器、精密机械组件及电子设备的制造和销售，业务遍及日本、中国、美洲、欧洲及国际市场，市值为 763.9 亿日元。</p>
</div><p><strong>Operations:</strong> The company's revenue primarily comes from its capacitors segment, which generated ¥127.20 billion.</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入主要来自其电容器部门，产生了 1272 亿日元的收入。</p>
</div><p><strong>Estimated Discount To Fair Value:</strong> 45.9%</p>
<div class="lb-trans"><p><strong>公允价值折扣估算：</strong> 45.9%</p>
</div><p>Nippon Chemi-Con, trading at ¥3,170, is significantly undervalued relative to its estimated future cash flow value of ¥5,864.2. Despite earnings growth of 45.3% last year and a projected annual profit increase of 52%, interest payments are not well covered by earnings. The company recently announced a private placement raising ¥9 billion from preferred shares issuance with the Development Bank of Japan Inc., adding financial flexibility amid share price volatility.</p>
<div class="lb-trans"><p>Nippon Chemi-Con 的交易价格为 3170 日元，显著低于其估算的未来现金流价值 5864.2 日元。尽管去年盈利增长了 45.3%，预计年利润将增加 52%，但利息支付未能得到盈利的良好覆盖。该公司最近宣布通过向日本开发银行发行优先股筹集 90 亿日元的私募，增加了在股价波动中的财务灵活性。</p>
</div><ul>
<li>In light of our recent growth report, it seems possible that Nippon Chemi-Con's financial performance will exceed current levels.</li>
<li>Get an in-depth perspective on Nippon Chemi-Con's balance sheet by reading our health report here.</li>
</ul>
<div class="lb-trans"><ul>
<li>根据我们最近的增长报告，Nippon Chemi-Con 的财务表现可能会超过当前水平。</li>
<li>点击这里阅读 Nippon Chemi-Con 的资产负债表健康报告，获取深入的视角。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/315324ed-d0c8-4ff1-baae-94405139c1a7/chart/dcf/query-dGhlbWU9bGlnaHQ" alt="" original-src="https://images.simplywall.st/company/315324ed-d0c8-4ff1-baae-94405139c1a7/chart/dcf?theme=light"/></p>
<p>TSE:6997 Discounted Cash Flow as at May 2026</p>
<div class="lb-trans"><p>TSE:6997 截至 2026 年 5 月的折现现金流</p>
</div><h2>Turning Ideas Into Actions</h2>
<div class="lb-trans"><h2>将想法转化为行动</h2>
</div><ul>
<li>Investigate our full lineup of 204 Undervalued Asian Stocks Based On Cash Flows right here.</li>
<li>Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments.</li>
<li>Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.</li>
</ul>
<div class="lb-trans"><ul>
<li>在这里调查我们基于现金流的 204 只被低估亚洲股票的完整阵容。</li>
<li>你是否已经将投资组合多样化到这些公司？利用 Simply Wall St 的投资组合功能，密切关注影响你投资的市场动态。</li>
<li>使用 Simply Wall St 提升你的投资组合，这是寻求全球市场覆盖的投资者的终极应用。</li>
</ul>
</div><h2>Want To Explore Some Alternatives?</h2>
<div class="lb-trans"><h2>想探索一些替代方案吗？</h2>
</div><ul>
<li>Explore high-performing small cap companies that haven't yet garnered significant analyst attention.</li>
<li>Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.</li>
<li>Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.</li>
</ul>
<div class="lb-trans"><ul>
<li>探索尚未获得显著分析师关注的高表现小型公司。</li>
<li>通过稳健的分红支付者来多样化您的投资组合，以应对潜在的市场波动。</li>
<li>充实您的投资组合，选择那些显示出强劲增长潜力的公司，这些公司得到了分析师和管理层的乐观展望支持。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation.</strong> We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>这篇文章来自 Simply Wall St，内容具有一般性。<strong>我们基于历史数据和分析师预测提供评论，采用无偏见的方法，我们的文章并不构成财务建议。它不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。</strong> 我们旨在为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div><h3><strong>New:</strong> Manage All Your Stock Portfolios in One Place</h3>
<div class="lb-trans"><h3><strong>新功能：</strong> 在一个地方管理您的所有股票投资组合</h3>
</div><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p>
<div class="lb-trans"><p>我们为股票投资者创建了 <strong>终极投资组合助手</strong>，<strong>而且是免费的。</strong></p>
</div><p>• Connect an unlimited number of Portfolios and see your total in one currency</p>
<div class="lb-trans"><p>• 连接无限数量的投资组合，并以一种货币查看您的总额</p>
</div><p>• Be alerted to new Warning Signs or Risks via email or mobile</p>
<div class="lb-trans"><p>• 通过电子邮件或手机接收新的警告信号或风险提示</p>
</div><p>• Track the Fair Value of your stocks</p>
<div class="lb-trans"><p>• 跟踪您股票的公允价值</p>
</div><p>Try a Demo Portfolio for Free</p>
<div class="lb-trans"><p>免费试用演示投资组合</p>
</div>

2026 年 5 月可能低于估值进行交易的亚洲股票